Mars

Last updated January 31, 2026

Innovation Areas

2,578

Inventors

Collaborations

Encapsulated cytokine cell delivery: MarsRecent Research Landscape

Uncontrolled therapeutic dosing from living implants leads to systemic toxicity or treatment failure. These systems integrate synthetic gene circuits with electronic hardware to modulate cellular secretion in real-time.

What technical problems is Mars addressing in Encapsulated cytokine cell delivery?

Insufficient therapeutic agent localization

(7)evidences

Systemic delivery of therapeutic agents often fails to reach effective concentrations at specific sites like damaged intestinal mucosa. Improving localized targeting prevents systemic toxicity and ensures sufficient therapeutic potency at the injury site.

Uncontrolled therapeutic agent release

(1)evidences

Static drug delivery systems cannot adapt to real-time physiological changes or patient needs. Dynamic control over agent release prevents systemic toxicity and suboptimal therapeutic windows.